The pharmacok
Table of Contents
Contributors xi
PART I DRUG DISCOVERY AND DEVELOPMENT 1
1 The Role of Chemical Biology in Drug Discovery 3
Andrew J. Pope
2 Computational Approaches to Drug Discovery and Development 23
Honglin Li, Mingyue Zheng, Xiaomin Luo, Weiliang Zhu, and Hualiang Jiang
3 Design and Selection of Small Molecule Inhibitors 41
Jianwei Che, Yi Liu, and Nathanael S. Gray
4 Lead Optimization in Drug Discovery 65
Craig W. Lindsley, David Weaver, Thomas M. Bridges, and J. Phillip Kennedy
5 Pharmacokinetics of Drug Candidates 83
Ronald E. White
6 ADME Properties of Drugs 101
Li Di and Edward H. Kerns
7 Drug Transport in Living Systems 115
Yael Elbaz and Shimon Schuldiner
8 Blood-Brain Barrier: Considerations in Drug Development and Delivery 133
David S. Miller and Brian T. Hawkins
9 Pharmacokinetic Considerations: Methods and Systems of Controlled Drug Delivery 147
Zhong Zuo and Vincent H. L. Lee
10 Pharmaceuticals: Natural Products and Natural Product Models 165
Sheo B. Singh
PART II CHEMICAL BIOLOGY TO UNDERSTAND AND TARGET DISEASE 203
11 The Role of Chemical Biology in Understanding and Treating
Disease—Are Small Molecule “Correctors” the Way of the Future? 205
David Selwood
12 Anxiety Disorders 215
Miklos Toth
13 Chronic Obstructive Pulmonary Disease (COPD) 245
Peter J. Barnes
14 Depression 267
Glen B. Baker and Nicholas D. Mitchell
15 Osteoarthritis 293
Marjolaine Gosset, Jeremie Sellam, Claire Jacques, nd Francis Berenbaum
16 Human Immunodeficiency Virus (HIV) 331
Joseph P. Vacca
17 Allergy and Asthma 341
Garry M. Walsh
18 Schizophrenia 357
Ferenc Martenyi
19 Protein Misfolding and Disease 379
Johanna C. Scheinost, Grant E. Boldt, and Paul Wentworth
20 Protein Trafficking Diseases 401
Heidi M. Sampson and David Y. Thomas
21 Metabolic Diseases 419
Cynthia M. Arbeeny
22 Mitochondrial Medicine 445
Richard J. T. Rodenburg and Jan A. M. Smeitink
23 Lysosomal Disorders 461
Doug A. Brooks and Maria Fuller
Index 483
